Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Michael Matthay and Daniel McAuley.
Michael Matthay
Connection Strength
0.686
Daniel McAuley
  1. Clinical trials in acute respiratory distress syndrome: challenges and opportunities. Lancet Respir Med. 2017 06; 5(6):524-534.
    View in: PubMed
    Score: 0.179
  2. Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Respir Med. 2017 06; 5(6):484-491.
    View in: PubMed
    Score: 0.179
  3. Erratum to: Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction - a randomised placebo-controlled trial (KARE): study protocol. Trials. 2017 05 11; 18(1):214.
    View in: PubMed
    Score: 0.179
  4. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26; 385(9):790-802.
    View in: PubMed
    Score: 0.060
  5. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Intensive Care Med. 2018 Nov; 44(11):1859-1869.
    View in: PubMed
    Score: 0.049
  6. Unexpected Role for Adaptive aßTh17 Cells in Acute Respiratory Distress Syndrome. J Immunol. 2015 Jul 01; 195(1):87-95.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.